Axxcess Wealth Management LLC grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 44.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,941 shares of the biotechnology company's stock after buying an additional 904 shares during the quarter. Axxcess Wealth Management LLC's holdings in Axon Enterprise were worth $1,748,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of AXON. Groupama Asset Managment purchased a new stake in Axon Enterprise in the third quarter worth $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth about $120,553,000. Proficio Capital Partners LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at about $78,414,000. Westfield Capital Management Co. LP increased its position in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after buying an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. raised its stake in Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock worth $86,354,000 after buying an additional 111,405 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.
Analyst Upgrades and Downgrades
AXON has been the topic of several research reports. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird lifted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price on the stock. Finally, The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of "Moderate Buy" and an average target price of $604.67.
Read Our Latest Stock Report on Axon Enterprise
Axon Enterprise Stock Up 2.2 %
AXON traded up $12.52 during trading on Monday, hitting $572.52. 689,483 shares of the company's stock traded hands, compared to its average volume of 842,467. The stock has a market capitalization of $43.87 billion, a price-to-earnings ratio of 147.94, a PEG ratio of 5.17 and a beta of 1.12. The company's 50 day simple moving average is $591.90 and its two-hundred day simple moving average is $543.57. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.
Insider Buying and Selling
In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by corporate insiders.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.